Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2023–2028 · cooperative agreement · U01
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of fasting-induced radioprotection of small intestinal epithelial cells
Helen M Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Deciphering pathways involved in topoisomerase II turnover
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Deciphering pathways involved in topoisomerase II turnover
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · fellowship · F99
Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer
Jose S Enriquez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Neuronal Alterations in the Midbrain Dopaminergic System Function: A Novel Mechanism of Radiation Induced Cognitive Dysfunction
Die Zhang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2025 · research · R21
Developing an inhibitor of EIF2AK1 to overcome ineffective erythropoiesis in myelodysplastic syndromes with ringed sideroblasts
Simona Colla · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Prevention
Implementation and Dissemination of an Evidence-Based Intervention to Increase Tobacco Treatment Capacity in Opioid Treatment Programs
Lorraine Reitzel · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2025 · research · R21
First-in-Human Imaging of Innate Immunity Activation with a Redox-Tuned PET Reporter
David Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Mapping the geospatial tumor clonal architecture to restore immune recognition in pancreatic cancer.
Andrea Viale · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R37
Repurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer
Johannes F Fahrmann · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2024 · fellowship · F32
The role of the gut microbiome in ICB-induced anti-tumor response and toxicity
Elizabeth M. Park · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
Or P. Gozani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Role of PRMT7 in Genomic Imprinting
Taiping Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma
Stephen Y Lai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2024 · award
The role of NDRG1 driven stemness in aggressive breast tumors
Taru Muranen · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2023–2028 · research · R01
The role of membrane homoeostasis of neural stem cell and glioma stem cells in neural development and gliomagenesis
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The role of membrane homoeostasis of neural stem cell and glioma stem cells in neural development and gliomagenesis
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
Vanderlei Bagnato · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Dissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancer
Ferdinandos Skoulidis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Health equity in fertility specialty care among cancer survivors
Jose Alejandro Rauh-Hain · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Normalizing membrane homeostasis in microglia/macrophages of pediatric high-grade gliomas
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2027 · research · R01
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
Guocan Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R37
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
Rahul Anil Sheth · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Studying and therapeutically targeting ferroptosis liability in BRCA1 deficient cancer
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R01
Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer
Chad Daniel Huff · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2026 · research · R21
Boosting anti-tumor immunity in the omentum for metastasis prevention
Honami Naora · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Molecular Mechanism of long Noncoding RNAs in Phenylketonuria
Vernon R Sutton · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2026 · research · R21
Quantitative Imaging of OXPHOS in Pancreatic Cancer
Henry Charles Manning · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
Guocan Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2026 · career development · K22
Enhancing the efficacy of immunotherapy by optimal use of SMAC mimetics
Shengqing Gu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Developing knowledge guided deep learning models to predict the binding between T cell receptors and neoantigens for facilitating TCR-T therapies
Tao Wang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2026 · research · R21
Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD)
Katherine Arnold Hutcheson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · award
Harmony & Health: A culturally adapted mind-body intervention to reduce sitting time and improve psychosocial wellbeing in Black adults
Scherezade Mama · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2023 · grant · LCRF–Daiichi Sankyo–AstraZeneca Research Grant on Antibody Drug Conjugates
2023 – LCRF–Daiichi Sankyo–AstraZeneca Research Grant on Antibody Drug Conjugates – University of Texas M.D. Anderson Cancer Center – Carl Gay, MD, PhD
Carl Gay · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2023–2027 · research · R01
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
Di Zhao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
